Latest News about RHHBY

Recent news which mentions RHHBY

...

12 13 14 15 16 17 18 19 Next >

These OTCQX & OTCQB Securities Had the Most Trading Activity in October

November 09, 2021

Should You Buy Pfizer Stock After the Fantastic COVID-19 Pill News?

November 09, 2021

Regeneron-Roche's COVID-19 Treatment Shows Long Term Benefit After Single Dose

November 08, 2021

Here's Why Merck Stock Vaulted Higher in October

November 08, 2021

The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More

November 08, 2021

Will Pfizer Outgun Merck With Oral COVID-19 Pill?

November 05, 2021

7 European Stocks to Buy to Diversify Your Portfolio

November 04, 2021

Novartis To Offload Its Stake Back To Roche For $20.7B

November 04, 2021

Galecto To Test GB1211 Combined with Roche's Tecentriq In First Line Lung Cancer Setting

November 02, 2021

2 Growth Stocks That Could Deliver 1,000% Returns

October 31, 2021

3 Beaten-Down Biotech Stocks -- Can They Recover?

October 31, 2021

How Atea's Clinical Flop Shakes Up the COVID-19 Pill Market

October 29, 2021

Should Biogen Investors Be Preparing for the Worst?

October 27, 2021

Are Atea Pharmaceuticals, Agenus, Novavax, and Ocular Therapeutix Bad News Buy?

October 24, 2021

Why Atea Pharmaceuticals Stock Got Crushed This Week

October 22, 2021

Why Ionis Pharmaceuticals Stock Is Down 13% This Week

October 22, 2021

The Daily Biotech Pulse: Athira CEO Resigns Over Doctored Research, Merck's Keytruda Snags First Approval For Breast Cancer In Europe, Minerva And Xilio IPOs

October 22, 2021

7 Penny Stocks to Buy to Sidestep the Noise on Wall Street

October 21, 2021

Are These 2 Companies Next for Short Squeezes?

October 21, 2021

Roche Expects Higher FY21 Sales As Delta Variant Boosts Demand For Diagnostics

October 20, 2021

AstraZeneca Pulls Plug On MCL-1 Cancer Drug Trial

October 20, 2021

The Daily Biotech Pulse: Novavax Retreats Amid Vaccine Issues, LumiraDx COVID Test Approved In India, Sesen Shines On Positive Bladder Cancer Review

October 20, 2021

Why Atea Pharmaceuticals Is Imploding Today

October 19, 2021

David v Goliath in The Race to Develop an Oral Therapy for COVID-19

October 19, 2021

The Daily Biotech Pulse: Entasis, Dermata Spike Higher On Positive Readouts, J&J Q3 EPS Beats Estimates, Wave Life Sciences Regains Right To CNS Portfolio

October 19, 2021

Why Are Atea Pharmaceuticals Shares Plunging Today?

October 19, 2021

Why Infinity Pharmaceuticals Shot Nearly 4% Higher Today

October 18, 2021

Roche's Tecentriq Wins FDA Approval In Adjuvant Lung Cancer Setting

October 18, 2021

The Week Ahead In Biotech (Oct. 18-23): J&J, Biogen Kickstart Big Pharma Earnings, Regeneron-Sanofi, Roche Await FDA Decisions And IPOs

October 18, 2021

3 COVID-19 Pill Stocks to Watch

October 16, 2021

...

12 13 14 15 16 17 18 19 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.